Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong><br />
4.2.6 Future <strong>Market</strong> Scenario<br />
4.2.7 <strong>Global</strong> Viagra <strong>Market</strong> for <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2015 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
4.3 Cialis (Tadalafil)<br />
4.3.1 Introduction<br />
4.3.2 <strong>Global</strong> Cialis <strong>Market</strong> for <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
4.3.3 Patent <strong>and</strong> Regulatory Scenario<br />
4.3.4 Current <strong>Market</strong> Scenario <strong>and</strong> Patent Expiry Effect<br />
4.3.5 <strong>Global</strong> Cialis <strong>Market</strong> for <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> 2014 (USD Million)<br />
4.3.6 Future <strong>Market</strong> Scenario<br />
4.3.7 <strong>Global</strong> Cialis <strong>Market</strong> for <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2015 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
4.4 Levitra/Staxyn (Vardenafil)<br />
4.4.1 Introduction<br />
4.4.2 <strong>Global</strong> Levitra/Staxyn <strong>Market</strong> for <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
4.4.3 Patent <strong>and</strong> Regulatory Scenario<br />
4.4.4 Current <strong>and</strong> Future <strong>Market</strong> Scenario<br />
4.4.5 <strong>Global</strong> Levitra/Staxyn <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> 2014 (USD Million)<br />
4.4.6 <strong>Global</strong> Levitra/Staxyn <strong>Market</strong> for <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2015 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
4.5 Stendra/Spedra (Avanafil)<br />
4.5.1 Introduction<br />
4.5.2 Future <strong>Market</strong> Scenario<br />
4.5.3 <strong>Global</strong> Stendra/Spedra <strong>Market</strong> for <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2015 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
Transparency <strong>Market</strong> Research<br />
7
Change language